pharma · Covid-19 · Chronic Myocardial Ischemia · LSTA
Lisata Therapeutics
LISATA THERAPEUTICS, INC.
Lisata Therapeutics trial registry — 16 ClinicalTrials.gov studies with program phase, status, and indication context.
110 Allen Road, 2nd Flr, Basking Ridge, NJ 07920, US HQ
2006 Founded
38 Employees
Public company Type
LSTA · NYSE Ticker
Company details
- Status
- Public
- HQ
- 110 Allen Road, 2nd Flr, Basking Ridge, NJ 07920, US
- Founded
- 2006
- Employees
- 38
- Programs
- 15
- Drugs
- 13
- Patents
- 1
Lisata Therapeutics clinical trials
Registry index of 16 ClinicalTrials.gov studies linked to Lisata Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Lisata Therapeutics trial registry — 16 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Lisata Therapeutics.
-
lymphokine-activated killer cells — Phase 2
Clinical update -
CLBS14 (low-dose) — Phase 2
Clinical update -
Auto-CD34+ cells — Phase 3
Clinical update -
CLBS119 — Phase 1
Clinical update -
therapeutic autologous dendritic cells — Phase 2
Clinical update -
NBS10 — Phase 2
Clinical update -
CLBS03 Low Dose — Phase 2
Clinical update -
CEND-1 — Phase 1
Clinical update